Morgan Stanley’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.06K | Hold |
3,105
| – | – | ﹤0.01% | 6987 |
|
2025
Q1 | $7.89K | Sell |
3,105
-911
| -23% | -$2.31K | ﹤0.01% | 6873 |
|
2024
Q4 | $8.76K | Buy |
4,016
+3,986
| +13,287% | +$8.69K | ﹤0.01% | 6855 |
|
2024
Q3 | $94 | Hold |
30
| – | – | ﹤0.01% | 7450 |
|
2024
Q2 | $89 | Hold |
30
| – | – | ﹤0.01% | 7376 |
|
2024
Q1 | $183 | Sell |
30
-30
| -50% | -$183 | ﹤0.01% | 7321 |
|
2023
Q4 | $598 | Sell |
60
-6
| -9% | -$60 | ﹤0.01% | 7259 |
|
2023
Q3 | $423 | Hold |
66
| – | – | ﹤0.01% | 7323 |
|
2023
Q2 | $2.63K | Hold |
66
| – | – | ﹤0.01% | 7136 |
|
2023
Q1 | $1.92K | Hold |
66
| – | – | ﹤0.01% | 7244 |
|
2022
Q4 | $2.05K | Hold |
66
| – | – | ﹤0.01% | 7366 |
|
2022
Q3 | $2K | Hold |
66
| – | – | ﹤0.01% | 7446 |
|
2022
Q2 | $1K | Hold |
66
| – | – | ﹤0.01% | 7657 |
|
2022
Q1 | $2K | Hold |
66
| – | – | ﹤0.01% | 7723 |
|
2021
Q4 | $2K | Sell |
66
-26
| -28% | -$788 | ﹤0.01% | 7780 |
|
2021
Q3 | $4K | Hold |
92
| – | – | ﹤0.01% | 7534 |
|
2021
Q2 | $5K | Buy |
92
+26
| +39% | +$1.41K | ﹤0.01% | 7370 |
|
2021
Q1 | $4K | Hold |
66
| – | – | ﹤0.01% | 7141 |
|
2020
Q4 | $3K | Buy |
66
+30
| +83% | +$1.36K | ﹤0.01% | 6838 |
|
2020
Q3 | $1K | Hold |
36
| – | – | ﹤0.01% | 6645 |
|
2020
Q2 | $1K | Sell |
36
-43
| -54% | -$1.19K | ﹤0.01% | 6510 |
|
2020
Q1 | $4K | Hold |
79
| – | – | ﹤0.01% | 6259 |
|
2019
Q4 | $4K | Buy |
79
+43
| +119% | +$2.18K | ﹤0.01% | 6416 |
|
2019
Q3 | $2K | Buy |
+36
| New | +$2K | ﹤0.01% | 6467 |
|